123 related articles for article (PubMed ID: 10525671)
1. Absence of glutamic acid decarboxylase antibodies in Pima Indian children with diabetes mellitus.
Dabelea D; Palmer JP; Bennett PH; Pettitt DJ; Knowler WC
Diabetologia; 1999 Oct; 42(10):1265-6. PubMed ID: 10525671
[No Abstract] [Full Text] [Related]
2. Diabetes-associated autoantibodies in aboriginal children.
Sellers E; Eisenbarth G; Young TK; Dean HJ
Lancet; 2000 Apr; 355(9210):1156. PubMed ID: 10791381
[TBL] [Abstract][Full Text] [Related]
3. Prevalence of antibodies to glutamic acid decarboxylase in women who have had gestational diabetes.
Beischer NA; Wein P; Sheedy MT; Mackay IR; Rowley MJ; Zimmet P
Am J Obstet Gynecol; 1995 Nov; 173(5):1563-9. PubMed ID: 7503202
[TBL] [Abstract][Full Text] [Related]
4. Difference between islet cell antibodies and autoantibodies to glutamic acid decarboxylase-containing Purkinje cells in IDDM.
Kobayashi T; Nakanishi K; Murase T; Kosaka K
Diabetes Care; 1992 Oct; 15(10):1435-6. PubMed ID: 1425115
[No Abstract] [Full Text] [Related]
5. Persisting antibodies to glutamic acid decarboxylase in type 1 (insulin-dependent) diabetes mellitus are not associated with neuropathy.
Tuomi T; Zimmet PZ; Rowley MJ; Serjeantson SW; Mackay IR
Diabetologia; 1993 Jul; 36(7):685. PubMed ID: 8359590
[No Abstract] [Full Text] [Related]
6. Seroconversion of glutamic acid decarboxylase antibodies in a patient initially diagnosed as having type 2 diabetes mellitus.
Nagai T; Imamura M; Mori M
Intern Med; 2005 Apr; 44(4):299-302. PubMed ID: 15897639
[TBL] [Abstract][Full Text] [Related]
7. Two amino acids in glutamic acid decarboxylase act in concert for maintenance of conformational determinants recognised by Type I diabetic autoantibodies.
Tree TI; Morgenthaler NG; Duhindan N; Hicks KE; Madec AM; Scherbaum WA; Banga JP
Diabetologia; 2000 Jul; 43(7):881-9. PubMed ID: 10952461
[TBL] [Abstract][Full Text] [Related]
8. Radioimmunoprecipitation assay for glutamic acid decarboxylase antibodies evaluated clinically with sera from patients with insulin-dependent diabetes mellitus.
Ohta M; Obayashi H; Takahashi K; Kitagawa Y; Nakano K; Matsuo S; Nishimura M; Itoh N; Ohta K
Clin Chem; 1996 Dec; 42(12):1975-8. PubMed ID: 8969635
[TBL] [Abstract][Full Text] [Related]
9. Detection of glutamic acid decarboxylase autoantibodies with the varelisa ELISA.
Gronowski AM; Wong EC; Wilhite TR; Martin DL; Smith CH; Parvin CA; Landt M
Clin Chem; 1995 Oct; 41(10):1532-4. PubMed ID: 7586530
[No Abstract] [Full Text] [Related]
10. GAD antibodies in IDDM in Thailand.
Rattarasarn C; Aguilar-Diosdado M; Soonthornpun S; Patarakijvanich N; Jaruratanasirikul S
Diabetes Care; 1996 Jun; 19(6):674-5. PubMed ID: 8725876
[No Abstract] [Full Text] [Related]
11. IgG4-subclass of glutamic acid decarboxylase antibody is more frequent in latent autoimmune diabetes in adults than in type 1 diabetes.
Hillman M; Törn C; Thorgeirsson H; Landin-Olsson M
Diabetologia; 2004 Nov; 47(11):1984-9. PubMed ID: 15565370
[TBL] [Abstract][Full Text] [Related]
12. Clinical and genetic characteristics of diabetic patients with high-titer (>10,000 U/ml) of antibodies to glutamic acid decarboxylase.
Ishii M; Hasegawa G; Fukui M; Obayashi H; Ohta M; Ogata M; Yoshioka K; Kitagawa Y; Nakano K; Yoshikawa T; Nakamura N
Immunol Lett; 2005 Jul; 99(2):180-5. PubMed ID: 16009268
[TBL] [Abstract][Full Text] [Related]
13. [A 81-year-old case of latent autoimmune diabetes mellitus in adult].
Wang TQ; Liu YS; Qu GY; Xiao X
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2004 Jun; 29(3):369. PubMed ID: 16136990
[No Abstract] [Full Text] [Related]
14. Isotypes of anti-islet autoantibodies.
Eisenbarth GS
Diabetes Care; 2000 Feb; 23(2):151-2. PubMed ID: 10868822
[No Abstract] [Full Text] [Related]
15. DPD epitope-specific glutamic acid decarboxylase (GAD)65 autoantibodies in children with Type 1 diabetes.
Bansal N; Hampe CS; Rodriguez L; O'Brian Smith E; Kushner J; Balasubramanyam A; Redondo MJ
Diabet Med; 2017 May; 34(5):641-646. PubMed ID: 26802570
[TBL] [Abstract][Full Text] [Related]
16. Glutamic acid decarboxylase antibodies in relation to other autoantibodies and genetic risk markers in children with newly diagnosed insulin-dependent diabetes. Childhood Diabetes in Finland Study Group.
Sabbah E; Kulmala P; Veijola R; Vähäsalo P; Karjalainen J; Tuomilehto-Wolf E; Akerblom HK; Knip M
J Clin Endocrinol Metab; 1996 Jul; 81(7):2455-9. PubMed ID: 8675560
[TBL] [Abstract][Full Text] [Related]
17. GADA and islet cell antibodies in Romanian children and adolescents with diabetes mellitus.
Serban V; Enache A; Vlad A; Sima A; Roşu M; Roşca A; Drăghici C
Rom J Intern Med; 2004; 42(2):325-32. PubMed ID: 15529623
[TBL] [Abstract][Full Text] [Related]
18. Negativation of type 1 diabetes-associated autoantibodies to glutamic acid decarboxylase and insulin in children treated with oral calcitriol.
Papadimitriou DT; Marakaki C; Fretzayas A; Nicolaidou P; Papadimitriou A
J Diabetes; 2013 Sep; 5(3):344-8. PubMed ID: 23302101
[TBL] [Abstract][Full Text] [Related]
19. Beta-cell autoantibodies in children with type 2 diabetes mellitus: subgroup or misclassification?
Reinehr T; Schober E; Wiegand S; Thon A; Holl R;
Arch Dis Child; 2006 Jun; 91(6):473-7. PubMed ID: 16449253
[TBL] [Abstract][Full Text] [Related]
20. Anti-GAD-positive patients with type 1 diabetes mellitus have higher prevalence of autoimmune thyroiditis than anti-GAD-negative patients with type 1 and type 2 diabetes mellitus.
Bárová H; Perusicová J; Hill M; Sterzl I; Vondra K; Masek Z
Physiol Res; 2004; 53(3):279-86. PubMed ID: 15209535
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
